申请人:——
公开号:US20020065253A1
公开(公告)日:2002-05-30
The present invention relates to a method of treating angiogenesis in tumor conditions in a mammal suffering therefrom which comprises administering to a mammal in need thereof an effective amount of a cyclic compound selected from the group consisting of cyclopentane, cyclohexane, cycloheptane, monosaccharide, disaccharide, trisaccharide, tetrasaccharide, piperidine, tetrahydrothiopyran, 5-oxotetrahydrothiopyran, 5,5-dioxotetrahydrothiopyran, tetrahydroselenopyran, tetrahydrofuran, pyrrolidine, tetrahydrothiophene, 5-oxotetrahydrothiophene, 5,5-dioxotetrahydrothiophene, tetrahydroselenophene, benzene, cumene, mesitylene, naphthalene and phenanthrene, in which said cyclic compound is substituted by at least three vicinal phosphorus containing radicals of the formula:
1
The present application is also directed to the use of these compounds for treating inflammatory conditions, tissue repair conditions and/or infectious conditions in a mammal.
本发明涉及一种治疗患有肿瘤的哺乳动物体内血管生成的方法,该方法包括向有需要的哺乳动物施用有效量的环状化合物,该环状化合物选自由环戊烷、环己烷、环庚烷、单糖、二糖、三糖、四糖、哌啶、四氢噻喃、5-氧代四氢噻喃、5,5-二氧代四氢噻喃、四氢硒喃、四氢呋喃、吡咯烷、四氢苯并呋喃、5-氧代四氢噻喃、四氢噻喃、5-氧代四氢噻喃、5,5-二氧代四氢噻喃、四氢呋喃、吡咯烷、四氢噻吩、5-氧代四氢噻吩、5,5-二氧代四氢噻吩、四氢硒吩、苯、积烯、间苯二酚、萘和菲,其中所述环状化合物至少被三个邻接的含磷基取代,其式如下
1
本申请还涉及使用这些化合物治疗哺乳动物的炎症、组织修复和/或感染性疾病。